Dewen Mao

548 total citations
31 papers, 207 citations indexed

About

Dewen Mao is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Dewen Mao has authored 31 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 12 papers in Hepatology and 10 papers in Pharmacology. Recurrent topics in Dewen Mao's work include Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (10 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Dewen Mao is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Liver Disease and Transplantation (10 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Dewen Mao collaborates with scholars based in China. Dewen Mao's co-authors include Hua Qiu, Rongzhen Zhang, Na Wang, Hanmin Li, Yong‐Liang Chu, Xianbo Wang, Fang Xie, Qianqian Zhang, Zuojiong Gong and Weizhi Wang and has published in prestigious journals such as Scientific Reports, FEBS Letters and Theranostics.

In The Last Decade

Dewen Mao

26 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dewen Mao China 9 78 73 65 40 31 31 207
Facheng Bai China 10 138 1.8× 93 1.3× 101 1.6× 41 1.0× 11 0.4× 14 268
Baoyu Liang China 7 90 1.2× 118 1.6× 62 1.0× 32 0.8× 13 0.4× 10 276
Wenxuan Yu China 11 42 0.5× 109 1.5× 105 1.6× 27 0.7× 16 0.5× 24 304
Sizhe Wan China 10 122 1.6× 124 1.7× 107 1.6× 43 1.1× 19 0.6× 18 279
Nashwa Abu‐Elsaad Egypt 12 93 1.2× 114 1.6× 75 1.2× 39 1.0× 11 0.4× 22 349
Mingliang Cheng China 7 129 1.7× 125 1.7× 99 1.5× 41 1.0× 12 0.4× 18 325
Hany M. Fayed Egypt 13 107 1.4× 82 1.1× 99 1.5× 64 1.6× 14 0.5× 24 307
Yufeng Xing China 9 115 1.5× 104 1.4× 51 0.8× 23 0.6× 26 0.8× 30 244
Luis Daniel Hernández‐Ortega Mexico 4 49 0.6× 52 0.7× 37 0.6× 28 0.7× 13 0.4× 9 211
Mao‐xu Ge China 11 157 2.0× 133 1.8× 123 1.9× 58 1.4× 22 0.7× 15 357

Countries citing papers authored by Dewen Mao

Since Specialization
Citations

This map shows the geographic impact of Dewen Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewen Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewen Mao more than expected).

Fields of papers citing papers by Dewen Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dewen Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewen Mao. The network helps show where Dewen Mao may publish in the future.

Co-authorship network of co-authors of Dewen Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Dewen Mao. A scholar is included among the top collaborators of Dewen Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dewen Mao. Dewen Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zhang, Rui, et al.. (2025). A self-assembled and H2O2-activatable hybrid nanoprodrug for lung infection and wound healing therapy. Theranostics. 15(12). 5953–5968. 3 indexed citations
4.
Zhang, Peng, Danan Gan, Xiaoling Chi, et al.. (2024). Regression-based Chinese norms of number connection test A and digit symbol test for diagnosing minimal hepatic encephalopathy. Scientific Reports. 14(1). 4005–4005.
5.
Mao, Dewen, Yang Zheng, Na Wang, et al.. (2023). Recent advances in pyroptosis, liver disease, and traditional Chinese medicine: A review. Phytotherapy Research. 37(12). 5473–5494. 5 indexed citations
6.
Mao, Dewen, et al.. (2023). Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure. Open Life Sciences. 18(1). 20220636–20220636. 4 indexed citations
7.
Yao, Chun, Meng Wang, Dewen Mao, et al.. (2023). Establishment and validation of a nomogram model for riskprediction of hepatic encephalopathy: a retrospective analysis. Scientific Reports. 13(1). 19544–19544. 1 indexed citations
8.
Wang, Xiufeng, et al.. (2022). Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 1 indexed citations
10.
Ye, Zhen, Qinfeng Huang, Yu Hu, et al.. (2022). A meritorious integrated medical regimen for hepatic fibrosis and its complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy. Frontiers in Medicine. 9. 920062–920062. 5 indexed citations
12.
Bai, Wenjie, et al.. (2022). The relationship between non-alcoholic fatty liver disease and incidence of chronic kidney disease for diabetic and non-diabetic subjects: A meta-analysis. Advances in Clinical and Experimental Medicine. 32(4). 407–414. 9 indexed citations
13.
Wang, Na, et al.. (2021). Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 7 indexed citations
14.
Hou, Yixin, Qianqian Zhang, Fangyuan Gao, et al.. (2020). Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC Gastroenterology. 20(1). 75–75. 20 indexed citations
15.
Wang, Na, et al.. (2020). Jie‐Du‐Hua‐Yu Granules Promote Liver Regeneration in Rat Models of Acute Liver Failure: miRNA‐mRNA Expression Analysis. Evidence-based Complementary and Alternative Medicine. 2020(1). 8180959–8180959. 4 indexed citations
16.
Qiu, Hua, Dewen Mao, Rongzhen Zhang, et al.. (2019). <p>The underlying mechanisms of Jie-Du-Hua-Yu granule for protecting rat liver failure</p>. Drug Design Development and Therapy. Volume 13. 589–600. 7 indexed citations
17.
Gao, Fangyuan, Qianqian Zhang, Yao Liu, et al.. (2018). Nomogram prediction of individual prognosis of patients with acute-on-chronic hepatitis B liver failure. Digestive and Liver Disease. 51(3). 425–433. 16 indexed citations
18.
Zhang, Rongzhen, et al.. (2017). Herbal Compound “Jiedu Huayu” Reduces Liver Injury in Rats via Regulation of IL‐2, TLR4, and PCNA Expression Levels. Evidence-based Complementary and Alternative Medicine. 2017(1). 9819350–9819350. 10 indexed citations
19.
Qiu, Hua, et al.. (2017). Subchronic toxicity of herbal compound “Jiedu Huayu” granules in rats. BMC Complementary and Alternative Medicine. 17(1). 450–450. 8 indexed citations
20.
Qiu, Hua, Yueqiu Gao, & Dewen Mao. (2015). Reptin physically interacts with p65 and represses NF‐κB activation. FEBS Letters. 589(15). 1951–1957. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026